Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia.
about
Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic optionsThe potential role of nemonoxacin for treatment of common infections.Nemonoxacin: first global approval.Development of novel antibacterial drugs to combat multiple resistant organisms.
P2860
Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia.
@en
Nemonoxacin
@nl
type
label
Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia.
@en
Nemonoxacin
@nl
prefLabel
Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia.
@en
Nemonoxacin
@nl
P2093
P2860
P50
P1476
Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia
@en
P2093
Chung-Chih Lai
Kuan-Yeh Lee
Yen-Hsu Chen
P2860
P304
P356
10.1586/14787210.2014.894881
P577
2014-03-03T00:00:00Z